Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Virtus Advisory Group is a Toronto-based capital markets advisory firm that provides investor relations, corporate development, strategic advisory, access-to-capital, and M&A support services to growth-oriented private and publicly listed companies. Founded in 2013, the firm positions itself as a strategic partner rather than a drug developer or healthcare operating company. Its client work appears to span multiple sectors, including technology, healthcare, and clean-tech, but the business itself is fundamentally a financial and communications advisory platform. For biotech analysts, Virtus Advisory Group is best understood as a service provider to issuers and investors, not as a therapeutics, diagnostics, or medical technology company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Virtus Advisory Group.